Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer.

Transl Oncol · 2024 · PMC11097084 · PMID 38718436

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Specifically, combining the above LINC00862 expression data, we found that LINC00862 showed a trend of shorter survival in LINC00862-high expressed tumors such as KIRC, LUAD, LIHC and STAD.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.